FREE Webinar: Ketamine, Psilocybin and New Drug Therapies
Uncategorized June 10, 2020 MJ Shareholders
Register HERE for our upcoming FREE webinar!
For the last 10 years, Harris Bricken attorneys have counseled countless domestic and international businesses and entrepreneurs on rapidly evolving laws and regulations in the cannabis, hemp, and cannabidiol (CBD) industries. As the legal and regulatory frameworks of those industries begin to solidify, new opportunities are emerging for the commercialization and research of new drug therapies and alternative medicine—everything from ketamine infusion clinics to psilocybin decriminalization. Our client roster has expanded rapidly in these areas over the past year or two as a result.
In an upcoming webinar on Thursday, July 9th at 12pm PT, Harris Bricken attorneys will address the future of legalization and regulation of new drug therapies and alternative medicine, including efforts to decriminalize and regulate psychedelics, federal and state controlled substances laws and regulations, Drug Enforcement Administration regulation, corporate practice of medicine issues and medical ventures, intellectual property strategies, and much more.
The panel will be moderated by Hilary Bricken (Los Angeles), with panelists Griffen Thorne (Los Angeles), Vince Sliwoski (Portland) and Jesse Mondry (Portland). The panelists will take questions throughout the presentation.
Register HERE today! And please submit any questions you may have when you register.
Until then, more information can be found on our psychedelics page, and in the blog posts below.
Ketamine
Psilocybin
MJ Shareholders
MJShareholders.com is the largest dedicated financial network and leading corporate communications firm serving the legal cannabis industry. Our network aims to connect public marijuana companies with these focused cannabis audiences across the US and Canada that are critical for growth: Short and long term cannabis investors Active funding sources Mainstream media Business leaders Cannabis consumers
